Viewing Study NCT04922450


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2025-12-28 @ 8:26 AM
Study NCT ID: NCT04922450
Status: UNKNOWN
Last Update Posted: 2021-06-10
First Post: 2021-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma
Sponsor: Hunan Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
None Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None immunotherapy View
None PD-1 checkpoint inhibitor View
None neoadjuvant chemotherapy View